全文获取类型
收费全文 | 668096篇 |
免费 | 55228篇 |
国内免费 | 20080篇 |
专业分类
耳鼻咽喉 | 5961篇 |
儿科学 | 15400篇 |
妇产科学 | 10664篇 |
基础医学 | 84841篇 |
口腔科学 | 13849篇 |
临床医学 | 59967篇 |
内科学 | 98900篇 |
皮肤病学 | 9899篇 |
神经病学 | 45268篇 |
特种医学 | 14750篇 |
外国民族医学 | 135篇 |
外科学 | 59209篇 |
综合类 | 95837篇 |
现状与发展 | 68篇 |
一般理论 | 33篇 |
预防医学 | 48554篇 |
眼科学 | 8847篇 |
药学 | 79806篇 |
431篇 | |
中国医学 | 42479篇 |
肿瘤学 | 48506篇 |
出版年
2023年 | 10531篇 |
2022年 | 14633篇 |
2021年 | 26716篇 |
2020年 | 24705篇 |
2019年 | 28518篇 |
2018年 | 26345篇 |
2017年 | 24084篇 |
2016年 | 22159篇 |
2015年 | 23819篇 |
2014年 | 40294篇 |
2013年 | 45006篇 |
2012年 | 38630篇 |
2011年 | 43634篇 |
2010年 | 36185篇 |
2009年 | 34789篇 |
2008年 | 33602篇 |
2007年 | 32232篇 |
2006年 | 28656篇 |
2005年 | 24847篇 |
2004年 | 20754篇 |
2003年 | 18044篇 |
2002年 | 14204篇 |
2001年 | 12380篇 |
2000年 | 10228篇 |
1999年 | 8866篇 |
1998年 | 6926篇 |
1997年 | 6608篇 |
1996年 | 5692篇 |
1995年 | 5824篇 |
1994年 | 5331篇 |
1993年 | 4421篇 |
1992年 | 4052篇 |
1991年 | 3602篇 |
1990年 | 3117篇 |
1989年 | 2665篇 |
1988年 | 2467篇 |
1987年 | 2045篇 |
1986年 | 1973篇 |
1985年 | 5045篇 |
1984年 | 5957篇 |
1983年 | 4162篇 |
1982年 | 4669篇 |
1981年 | 4239篇 |
1980年 | 3730篇 |
1979年 | 3357篇 |
1978年 | 2867篇 |
1977年 | 2192篇 |
1976年 | 2395篇 |
1975年 | 1803篇 |
1974年 | 1542篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
《Saudi Pharmaceutical Journal》2022,30(8):1153-1158
BackgroundMigraine is one of the neurological diseases that have a negative impact on subjects’ productivity and daily activity of patients. Introducing monoclonal antibodies as a valuable option for resolving the persistent problem of migraine is still under investigation. The current study aimed to evaluate the efficacy and safety profile related to Erenumab.MethodsA prospective study for clinical data collection and analysis from recruited therapy-refractory migraine subjects were carried through 6 months for each subject. All subjects received Erenumab 70 mg monthly. Each patient provided the clinical data monthly starting from 0 months and for the next 6 months. Migraine disability assessment (MIDAS) questionnaire was used for evaluation of the Erenumab efficacy every 3 months. In addition, data regarding adverse effects, migraine triggers, and the impact of previous COVID-19 on migraine severity were collected and analyzed.ResultsNinety subjects were recruited in the study. Erenumab injections resulted in a significant (p < 0.001) reduction in MIDAS score in the 3rd month compared with baseline, also this significance was continuous in the 6th month. In contrast, there was no significant difference in the 6th month compared with the 3rd. Previously infected COVID-19 subjects showed a higher severity of migraine attacks compared with non-infected subjects. Skin redness and local pain were the most common adverse effects 63.3%, 47.77% respectively associated with Erenumab.ConclusionUsing Erenumab therapy showed a great beneficial impact regarding the reduction of migraine-related disabilities. COVID-19 was related to the increased severity of migraine attacks. 相似文献
32.
33.
Mixed lineage leukemia 1(MLL1)是组蛋白甲基转移酶SET家族的成员之一。MLL1与WDR5、RbBP5、Ash2L和DPY-30组成MLL1甲基转移酶复合物调控组蛋白H3的第4位赖氨酸的甲基化水平,对造血系统的发育和血细胞的更新至关重要。部分白血病患者体内存在因MLL1基因易位而产生的致癌蛋白——MLL1融合蛋白,MLL1融合蛋白在发挥其致癌作用时需要功能完整的MLL1酶复合物,故靶向MLL1-WDR5的蛋白-蛋白相互作用成为治疗MLL1融合型白血病的潜在策略。本文对MLL1-WDR5蛋白-蛋白相互作用的生物学机制、结构信息以及抑制剂进行了系统的总结,并结合已报道数据对该领域进行了展望,以期为后续研究提供参考。 相似文献
34.
《The Journal for Nurse Practitioners》2022,18(2):245-247
Transient stress hyperglycemia in the setting of acute myocardial infarction is a frequent phenomenon. Its transient nature should not dissuade the clinician from management of elevated blood glucose in a patient after an ST-elevation myocardial infarction. This case presents an adult patient after an ST-elevation myocardial infarction with transient stress hyperglycemia and the evidence used to identify optimal pharmacologic management and secondary prevention. 相似文献
35.
36.
《The Journal for Nurse Practitioners》2022,18(4):370-371
From the early days of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, there were concerns that nebulizers used for the treatment of respiratory diseases as aerosol-generating devices could enhance the transmission of SARS-CoV-2. However, given the absence of any compelling data showing that nebulized treatments increase the risk of SARS-CoV-2 infection, it is unnecessary for community-dwelling patients with respiratory diseases to alter their current therapies, including nebulized treatments, to prevent symptom exacerbations. Maintaining current inhaled therapies also minimizes the risk of hospitalization and hospital-acquired infection of SARS-CoV-2. 相似文献
37.
38.
39.
40.
《Gait & posture》2022
ObjectiveThe aim of this study was to determine whether there is a difference in postural control between nulligravida women and women who have given birth by vaginal or cesarean section.MethodsWomen who had only vaginal delivery in the previous 1–3 years were included in the vaginal delivery group (n = 27), those who had only cesarean delivery in the previous 1–3 years were included in the cesarean section group (n = 28), and those who had never given birth were included in the control group (n = 32). Evaluations were administered 6–8 days after the ovulation phase. Postural control of the participants was evaluated with the computerized dynamic posturography device.ResultsA total of 87 women with a mean age of 29.4 ± 4 years and a mean body mass index of 24.1 ± 3.1 kg/m2 were included in the study. Antero-posterior somatosensory organization test values of the vaginal delivery group were lower than the control group (p = 0.0016). The cesarean delivery group had statistically lower antero-posterior somatosensory (p < 0.001 and p = 0.0013) and medio-lateral somatosensory (p = 0.002 and p = 0.017, respectively) test scores compared to the control group and the vaginal delivery group.ConclusionsIt was observed that women who birthed with vaginal or cesarean delivery had impaired somatosensory postural control. There is definitely a need for further studies with a long-term follow-up examining the effects of postural control during pregnancy and the postpartum period. 相似文献